EEG-guided Cognitive Pacing Tool During Concussion Recovery

Status Not yet recruiting

Clinical Trial Summary

This investigation will assess the utility of a novel wearable electroencephalography (EEG) headband linked to a mobile application to monitor cognitive activity post-concussion, and alert a patient when it is time to take a mental break. Personalized cloud-based machine learning algorithms will analyze EEG data in real-time for neural features indicative of mental workload and mental fatigue, and will notify a patient when it is time to rest based on these measures. It is hypothesized that this technology may provide a much needed data-driven management tool to better inform the cognitive pacing process for both patients with concussion, as well as their clinicians.

Clinical Trial Description

Despite advancements in the field of concussion care, the individualized nature and nuances of concussion make it a difficult condition to manage. It has been shown that both complete rest or too much activity can prolong recovery from concussion, indicating there is an ideal zone of activity that can aid in concussion recovery. Heart-rate guided sub-symptom aerobic physical activity has been shown to speed concussion recovery and provide an objective measure for patients with concussion to inform their rehabilitative physical activities. However, no such equal exists for guiding cognitive pacing. This study will utilize a wearable EEG headband linked to a mobile application to monitor cognitive activity post-concussion, and alert a patient when it is time to take a mental break. Personalized cloud-based machine learning algorithms will analyze EEG data in real-time for neural features of mental workload and mental fatigue, and will notify a patient when it is time to rest based on these measures. These algorithms have been developed and validated on healthy participants, and refined in concussion patients in an ongoing observational investigation yet to be published. The proposed investigation is a randomized, prospective pilot study to test the early efficacy of this technology in concussion recovery compared to standard of care alone. The results of this pilot investigation will be used to inform a future large-scale clinical trial to confirm the efficacy of this technology on concussion recovery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05522855
Study type	Interventional
Source	Neurovine Inc.
Contact	M Kennedy
Phone	1-844-340-0040
Email	research@neurovine.ai
Status	Not yet recruiting
Phase	N/A
Start date	May 2023
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04109677` - AIM CONTROL and SWECON - Handball The SWEdish CONcussion Study in Elite Handball
Recruiting	`NCT04932278` - The Role of Osteopathic Manipulative Medicine in Recovery From Concussions	N/A
Withdrawn	`NCT05062148` - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery	N/A
Recruiting	`NCT05682677` - Combined Neuromodulation and Cognitive Training for Post-mTBI Depression	N/A
Recruiting	`NCT04992130` - Sport Concussion Performance-Based Prevention Program	N/A
Completed	`NCT05095012` - RECOVER Clinical Pathway for Pediatric Concussion	N/A
Recruiting	`NCT05886400` - The Effects of Environmental Distractions on SCAT6 Outcomes	N/A
Active, not recruiting	`NCT05400551` - Craneofacial Injuries in Rink Hockey Athletes
Recruiting	`NCT04121780` - Growth Hormone Replacement Therapy for Retried Professional Football Players	Phase 2
Withdrawn	`NCT03575741` - Postural Control in Children and Adolescents After Suffering From a Concussion
Active, not recruiting	`NCT05471791` - Development of a Concussion Management Platform for Children and Youth	N/A
Completed	`NCT04730167` - The Monaco Initiative for Concussion in Motorsport Pilots
Completed	`NCT03478059` - Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI	N/A
Recruiting	`NCT05685121` - A Wrist-Worn Nerve Stimulator for Remediating Persistent Post-Concussive Symptoms in Adolescents	N/A
Completed	`NCT04122274` - Comparing and Interactive Concussion Education Platform to Current Education Standards	N/A
Completed	`NCT04558346` - Ghrelin (OXE--103) for Acute Concussion Management	Phase 2
Completed	`NCT04074486` - Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
Not yet recruiting	`NCT05562232` - The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms	N/A
Recruiting	`NCT05326555` - Dynamic Vision Testing and Concussion Management Dream Team 65
Completed	`NCT03671083` - Validation of Brain Function Assessment Algorithm for mTBI/Concussion

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.